Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Notes
Xanthocidin Derivatives as Topoisomerase IIα Enzymatic Inhibitors
Shuso TakedaKentaro YajiKenji MatsumotoToshiaki AmamotoMitsuru ShindoHironori Aramaki
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2014 Volume 37 Issue 2 Pages 331-334

Details
Abstract
Few studies have examined xanthocidin, a biotic isolated from Streptomyces xanthocidicus in 1966, because its supply is limited. Based on its chemical structure, xanthocidin has the potential to become a lead compound in the production of agrochemicals and anti-cancer drugs; however, it is unstable under both basic and acidic conditions. We recently established the total synthesis of xanthocidin using the FeCl3-mediated Nazarov reaction, and obtained two stable derivatives (#1 and #2). The results of the present study demonstrated that these derivatives exhibited the inhibitory activity of topoisomerase IIα, known as a molecular target for cancer chemotherapy, and this was attributed to the respective exo-methylene ketone group without DNA intercalation. The results obtained also suggest that these derivatives may have value as lead compounds in the synthesis of topoisomerase IIα inhibitors.
Content from these authors
© 2014 The Pharmaceutical Society of Japan
Previous article
feedback
Top